DE3585134D1 - Stabile arzneimittelzusammensetzungen von beta-adrenergetischen rezeptorblockierungsagenzien mit kurzer wirkung. - Google Patents

Stabile arzneimittelzusammensetzungen von beta-adrenergetischen rezeptorblockierungsagenzien mit kurzer wirkung.

Info

Publication number
DE3585134D1
DE3585134D1 DE8585901816T DE3585134T DE3585134D1 DE 3585134 D1 DE3585134 D1 DE 3585134D1 DE 8585901816 T DE8585901816 T DE 8585901816T DE 3585134 T DE3585134 T DE 3585134T DE 3585134 D1 DE3585134 D1 DE 3585134D1
Authority
DE
Germany
Prior art keywords
adrenergic receptor
blocking agents
receptor blocking
beta adrenergic
medicine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585901816T
Other languages
English (en)
Inventor
Agustin Escobar
M Wagenknecht
S Alam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Application granted granted Critical
Publication of DE3585134D1 publication Critical patent/DE3585134D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8585901816T 1984-04-09 1985-03-25 Stabile arzneimittelzusammensetzungen von beta-adrenergetischen rezeptorblockierungsagenzien mit kurzer wirkung. Expired - Lifetime DE3585134D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/598,131 US4579867A (en) 1984-04-09 1984-04-09 Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
PCT/US1985/000491 WO1985004581A1 (en) 1984-04-09 1985-03-25 Stable pharmaceutical compositions of short-acting beta-adrenergic receptor blocking agents

Publications (1)

Publication Number Publication Date
DE3585134D1 true DE3585134D1 (de) 1992-02-20

Family

ID=24394367

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585901816T Expired - Lifetime DE3585134D1 (de) 1984-04-09 1985-03-25 Stabile arzneimittelzusammensetzungen von beta-adrenergetischen rezeptorblockierungsagenzien mit kurzer wirkung.

Country Status (9)

Country Link
US (1) US4579867A (de)
EP (1) EP0179807B1 (de)
JP (1) JPS61501774A (de)
AU (1) AU575152B2 (de)
CA (1) CA1242146A (de)
DE (1) DE3585134D1 (de)
IT (1) IT1181627B (de)
WO (1) WO1985004581A1 (de)
ZA (1) ZA852321B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798892A (en) * 1981-11-12 1989-01-17 E. I. Du Pont De Nemours And Company 2-hydroxypropylamine heteroaryl ester derivatives
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US4897417A (en) * 1988-12-15 1990-01-30 E. I. Du Pont De Nemours & Co. Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (de) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-Informatiksystem
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN113533707B (zh) * 2021-07-13 2024-05-28 重庆德方信息技术有限公司 尿液检测卡自动装配装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1476934A (en) * 1922-02-13 1923-12-11 Abbott Lab Anaesthetic compound
NL301580A (de) * 1962-12-11
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4402974A (en) * 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
JPS5822464A (ja) * 1981-07-31 1983-02-09 Fuji Electric Co Ltd マルチプロセツサの制御方式
JPS5822465A (ja) * 1981-07-31 1983-02-09 Hitachi Ltd 磁気デイスク装置システム

Also Published As

Publication number Publication date
ZA852321B (en) 1985-11-27
IT8547928A0 (it) 1985-04-05
EP0179807A4 (de) 1987-10-27
AU575152B2 (en) 1988-07-21
AU4150285A (en) 1985-11-01
IT8547928A1 (it) 1986-10-05
CA1242146A (en) 1988-09-20
EP0179807B1 (de) 1992-01-08
WO1985004581A1 (en) 1985-10-24
EP0179807A1 (de) 1986-05-07
US4579867A (en) 1986-04-01
IT1181627B (it) 1987-09-30
JPS61501774A (ja) 1986-08-21

Similar Documents

Publication Publication Date Title
BR8502238A (pt) Composicao,uso da mesma e compostos
FI892368A0 (fi) Filterenhet foer anvaendning i hoega temperaturer.
DE3579196D1 (de) Mikrobizide enthaltende filmbildende mischung.
DE3580711D1 (de) Fluessigkristalle mit alkenyl- oder alkenyloxygruppen.
DE3575574D1 (de) Fluessige bleichmittelzusammensetzungen.
DE3583880D1 (de) Stabile interleukin-2-zusammensetzung.
IT8323762A0 (it) Derivati glicosilati dell&#39;insulina.
DE3586503D1 (de) Photohaertbare zusammensetzung.
BR8407183A (pt) Composicao inseticida
FI871918A0 (fi) Komposition och foerfarande foer att foerhindra mikrobvaext.
IT8419790A0 (it) Derivati pirido-benzotiazinici ad elevata attivita&#39; antimicrobica.
DE3585134D1 (de) Stabile arzneimittelzusammensetzungen von beta-adrenergetischen rezeptorblockierungsagenzien mit kurzer wirkung.
IT8521865A0 (it) Derivati di etilendiamminomonoammidi.
DK236185D0 (da) Stabiliseret insulin-formulering
DE3686673D1 (de) Strahlenhaertbare harzzusammensetzung.
DE3781708D1 (de) Temperaturregulierende beschichtungszusammensetzung.
DE3587842D1 (de) Spannungsgesteuertes Dioden-Dämpfungsglied.
DE3575072D1 (de) Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2.
DE3583360D1 (de) Fluessigkristallzusammensetzung.
DE3779956D1 (de) Photohaertbare zusammensetzung.
DE3585473D1 (de) Fluessigkristallzusammensetzung.
DK301585A (da) Anvendelse af actinonin som immunpotentiator
BR8402770A (pt) Composicao inseticida
ATA306085A (de) Insektizide zusammensetzungen
DE3583096D1 (de) Fluessigkristallzusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE DU PONT MERCK PHARMACEUTICAL CO., WILMINGTON,

8339 Ceased/non-payment of the annual fee